Clinical Trial Update: Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of a combination stem cell therapy for severe coronary ischemia has completed. The sponsor is TCA Cellular Therapy and the study addresse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Arteriosclerosis
• Coronary Artery Disease
• Coronary Atherosclerosis
• Coronary Ischemia

Drugs mentioned

• Combination Stem Cell Therapy

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Coronary Ischemia, Coronary Disease | Phase 1 | Status: COMPLETED